Report Search Results	As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 34) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 24-Nov-09 ValuEngine, Inc. N/A ValuEngine Industry Report for HOME HEALTH CARE 18 $49     View Abstract 23-Nov-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for TRIB 13 $25     View Abstract 23-Nov-09 Market Edge N/A Market Edge Equity Research Report 4 $10     View Abstract 22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: TRINITY BIOTECH PLC 5 $25     View Abstract 21-Nov-09 Standard & Poor's Quantitative Report N/A Trinity Biotech plc ADR 5 $25     View Abstract 21-Nov-09 Pechala's Reports Lubomir Pechala TRINITY BIOTECH PLC (TRIB=US) 2-weeks forecast 1 $10     View Abstract 21-Nov-09 Pechala's Reports Frantisek Pechala TRINITY BIOTECH PLC (TRIB=US) 12-months forecast 1 $15     View Abstract 17-Nov-09 Zacks Investment Research Inc. N/A TRINITY BIOTECH (TRIB) Zacks Company Snapshot 1 $10     View Abstract 17-Nov-09 EconomicInvestor N/A "The Economy Matters" Report for TRIB: the economy's impact on TRIB's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15     View Abstract 16-Nov-09 PriceTarget Research, Inc. N/A Trinity Biotech PLC has a current Overall Rating of A (Highest Rating). 7 $25     View Abstract Next 20

Brokerage Reports (Showing 1 to 10 of 10) Release Date  Contributor Author Title Pages Price StarMine Author Rating More Info EPS Accuracy * Portfolio Return ** 22-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 18 $50     View Abstract 22-Oct-09 Thomson StreetEvents N/A TRIB - Event Transcript of Trinity Biotech conference call, Oct. 21, 2009 / 4:00pm ET 18 $75     View Abstract 21-Oct-09 Roth Capital Partners, Inc. Matt Dolan EPS Beat Shows Continued Efficiencies; HIV Should Recover; Maintain Buy 7 $25     View Abstract 21-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 18 $50     View Abstract 20-Oct-09 Roth Capital Partners, Inc. Matt Dolan Trinity Biotech (TRIB) 3Q09 Earnings Preview 3 $10     View Abstract 20-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 13 $50     View Abstract 15-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 14 $50     View Abstract 14-Oct-09 Roth Capital Partners, Inc. Matt Dolan 3Q09 Medical Device Earnings Preview: Part 1 6 $25     View Abstract 12-Oct-09 Roth Capital Partners, Inc. Research Department Morning Call Summary 13 $50     View Abstract 9-Oct-09 Roth Capital Partners, Inc. Matt Dolan 3Q 2009: Quarterly Medical Device Trading & Acquisition Valuation Update 8 $25     View Abstract

Independent Reports (Showing 1 to 10 of 24) Release Date  Contributor Author Title Pages Price More Info 24-Nov-09 ValuEngine, Inc. N/A ValuEngine Industry Report for HOME HEALTH CARE 18 $49 View Abstract 23-Nov-09 ValuEngine, Inc. N/A ValuEngine Detailed Valuation Report for TRIB 13 $25 View Abstract 23-Nov-09 Market Edge N/A Market Edge Equity Research Report 4 $10 View Abstract 22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: TRINITY BIOTECH PLC 5 $25 View Abstract 21-Nov-09 Standard & Poor's Quantitative Report N/A Trinity Biotech plc ADR 5 $25 View Abstract 21-Nov-09 Pechala's Reports Lubomir Pechala TRINITY BIOTECH PLC (TRIB=US) 2-weeks forecast 1 $10 View Abstract 21-Nov-09 Pechala's Reports Frantisek Pechala TRINITY BIOTECH PLC (TRIB=US) 12-months forecast 1 $15 View Abstract 17-Nov-09 Zacks Investment Research Inc. N/A TRINITY BIOTECH (TRIB) Zacks Company Snapshot 1 $10 View Abstract 17-Nov-09 EconomicInvestor N/A "The Economy Matters" Report for TRIB: the economy's impact on TRIB's price and risk, featuring the powerful EconomicInvestor Star Rating 6 $15 View Abstract 16-Nov-09 PriceTarget Research, Inc. N/A Trinity Biotech PLC has a current Overall Rating of A (Highest Rating). 7 $25 View Abstract Next 14